Genomic Valley Biotech submits un-audited financial results

12 Nov 2019 Evaluate

Genomic Valley Biotech has informed that it has enclosed the Un-Audited Financial Results of the Company for the Quarter and Half Year ended 30th September, 2019 duly approved by the Board of Directors of the Company, at its meeting held today, the 12th day of November, 2019. The Meeting of Board of Directors of the Company commenced at 11:45 am and concluded at 02:35 pm. Also enclosed a copy of the Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Share Price

25.69 -0.29 (-1.12%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1534.85
Mangalam Global Ent 13.55
Kaveri Seed 899.50
Regaal Resources 67.86
Simran Farms 163.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×